1986年WHO镇痛阶梯的误用:将阿片类药物标记为弱或强的陷阱
本文指出1986年WHO癌症疼痛缓解指南将阿片类药物分为弱或强两类,该分类已被无意和故意误用,导致阿片类药物使用和滥用的危害。2018年WHO镇痛阶梯更新推荐高 potency 阿片联合简单镇痛药用于维持镇痛,也适用于需要短期阿片类药物的患者。作者认为所有阿片类药物无论弱强均有内在危害,应停止任意分类。
要点
- 1986年WHO将阿片类分为弱或强已被误用并导致危害。
- 2018年更新推荐高 potency 阿片联合简单镇痛药维持镇痛。
- 所有阿片类药物均有内在危害,应停止弱/强任意分类。
核心结论
- 应停止将阿片类药物任意分类为弱或强,因为该描述对处方者和消费者均无帮助。
研究设计与样本
- 本文为评论文章,未报告系统检索范围或样本量。
主要发现
- 1986年WHO癌症疼痛缓解指南将阿片类分为弱或强,该分类已被无意和故意误用,导致阿片使用和滥用危害。
- 2018年WHO镇痛阶梯更新推荐高 potency 阿片联合简单镇痛药维持镇痛优于替代镇痛药,也适用于需要短期阿片类药物的患者。
关键数值与推荐
- 2018年WHO更新推荐:高 potency 阿片联合简单镇痛药用于维持镇痛。
临床怎么用
- 临床应避免使用弱或强阿片类的任意分类,并考虑高 potency 阿片联合简单镇痛药用于维持镇痛。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Opioids have a vital role in alleviating pain from cancer and surgery. Despite good intentions, it is now recognised that the original WHO Cancer Pain Relief guidance from 1986, in which opioids were classified as either weak or strong, has been both inadvertently and purposefully misused, thereby contributing to harm from opioid use and misuse. However, the recommendation in the 2018 update of the WHO analgesic ladder that a combination of a high-potency opioid with simple analgesics is better than alternative analgesics for the maintenance of pain relief is also applicable to patients who require short-term opioids. Furthermore, because potential harm through opioid use and misuse is intrinsic to all opioids, whether weak or strong, we argue that the arbitrary classification of opioids either as weak or strong should be discontinued, as this description is not helpful to either prescribers or consumers.
引用
- Crush J, Levy N, Knaggs RD, et al. Misappropriation of the 1986 WHO analgesic ladder: the pitfalls of labelling opioids as weak or strong. Br J Anaesth. 2022. PMID: 35397880. doi:10.1016/j.bja.2022.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。